Manufacturers Life Insurance Company, The Janux Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 63,512 shares of JANX stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,512
Previous 30,595
107.59%
Holding current value
$1.91 Million
Previous $1.39 Million
144.78%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding JANX
# of Institutions
228Shares Held
54.7MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$311 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$107 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$106 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$91.9 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$70.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.25B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...